KDIGO 2026 CLINICAL PRACTICE GUIDELINE FOR ACUTE KIDNEY INJURY (AKI) AND ACUTE KIDNEY DISEASE (AKD)

CHAPTER 1. AKI AND AKD DEFINITION, IDENTIFICATION, AND CLASSIFICATION

By agreeing to provide feedback on this draft guideline document, you hereby permit KDIGO to acknowledge your participation as a reviewer in the final publication.

**Please type your name as you wish for it to appear in the Guideline.**
(Required.)
1.1. Definition of AKI
Practice Point 1.1.1: Acute kidney injury (AKI) in children and adults is defined by the presence of one or more abnormalities of kidney function or structure known or presumed to have occurred within up to 7 days, in the appropriate clinical context (Table 1).
Recommendation 1.1.1: We suggest using serum cystatin C to identify AKI in children and adults in clinical situations when serum creatinine (SCr) is less accurate (2B).
Practice Point 1.1.2: A baseline SCr value should be ascertained for all patients with suspected or confirmed AKI.
Practice Point 1.1.3: In adults, select the baseline SCr or cystatin C for an AKI episode using a hierarchical approach (Figure 1).
Figure 1 from the KDIGO AKI/AKD Guideline Public Review Draft
Chapter 1.1 Comments
4 / 54
7%